Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...
The clinic will be able to accommodate 1,500 patients over a long period and 50 patients with a left ventricular assist ...
Longer times from symptom onset to randomization equaled a smaller—or perhaps no—advantage for Impella vs standard care.
Stockhead on MSN
Scott Power: ASX healthcare stocks lift as sentiment improves
Morgans Scott Power positive of renewed momentum in the healthcare sector, which has risen 0.7% in the week ending January 16 ...
The Global Ventricular Tachycardia Market is estimated to be valued at USD 15.52 Bn in 2025 and is expected to reach USD 22.28 Bn by 2032, reflecting a compound annual growth rate (CAGR) of 5.3% from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results